Dr. Molina is head of the research group in Pneumology IDIBELL and head of the Functional Unit of Interstitial Lung of the Pneumology Service of the University Hospital of Bellvitge (HUB). She is also an associate professor at the University of Barcelona (UB).

She graduated in Medicine at the UB, specialised in pneumology, and subsequently sub-specialised in diffuse interstitial lung diseases and completed a postdoctoral stay in bioscience at Michigan State University. In 2008 she joined IDIBELL and the University Hospital of Bellvitge (HUB) where, since then, she directs the Pneumology laboratory.

She currently leads, among others, the PRECISION-ILD Precision Medicine project, which aims to improve early diagnosis and personalized treatment of interstitial lung diseases by finding useful biomarkers and applying data interpretation techniques based on artificial intelligence and computational modelling. Her research on the process of fibrosis in the lung was of great relevance, specially during the COVID-19 pandemic when it was discovered that lung damage caused by SARS-CoV-2 virus infection was mediated through ACE-2.

To date, she has published more than 200 articles, of which she is the first or last author in more than 50, accumulates nearly 10,000 citations and has an h-factor of 37. Her translational research goals with an impact on clinical practice, and her capacity for national and international, multidisciplinary and multilevel networking are noteworthy, which have led her to scientifically direct the CIBER of Respiratory Diseases from 2023.